Longitudinal Study for Central Nervous System Vasculitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania
About this trial
Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.
Eligibility criteria
Qualifiers
The presence of an acquired and otherwise unexplained neurologic deficit
The presence of either classic angiographic or histopathologic features of angiitis in the CNS
No evidence of systemic vasculitis or any condition that could cause the angiographic or pathologic features
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
6Canada
St. Joseph's Healthcare Hamilton Canada
University of Toronto/Sinai Health Toronto Canada
United States
Mayo Clinic55905, RochesterMinnesota, United States
Cleveland Clinic44195, ClevelandOhio, United States
Sponsors and collaborators
University of Pennsylvania
Lead sponsor
The Cleveland Clinic
Collaborator
Source ClinicalTrials.gov